Company Filing History:
1 out of 12 
1 out of 1 
1 out of 5 Years Active: 2003-2014
Title: Nicolas Leberre: Innovator in HIV Protease Inhibitors
Introduction
Nicolas Leberre is a notable inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of HIV protease inhibitors. With a total of 3 patents to his name, his work has the potential to impact the treatment of HIV.
Latest Patents
Leberre's latest patents focus on innovative formulations of HIV protease inhibitors. These inventions provide various chemical structures, including formulas I, IA, IB, Ib, or II, along with their pharmaceutically acceptable salts. The compounds include diverse groups such as 2-pyridyl, 3-pyridyl, and 4-pyridyl, as well as sulfonyl groups like benzenesulfonyl and thiophenesulfonyl. His work also explores the selection of R groups, which can include piperonyl and 2-pyrazinyl, among others.
Career Highlights
Throughout his career, Nicolas Leberre has worked with several prominent companies in the pharmaceutical industry. Notable among these are Pharmacor Inc. and Taimed Biologies, Inc. His experience in these organizations has contributed to his expertise in drug development and innovation.
Collaborations
Leberre has collaborated with various professionals in his field, including Brent Richard Stranix and Jean-Francois Lavallee. These partnerships have likely enhanced his research and development efforts, leading to successful innovations.
Conclusion
Nicolas Leberre stands out as an influential inventor in the realm of HIV protease inhibitors. His contributions through patents and collaborations reflect his commitment to advancing medical science and improving treatment options for patients.